Randomised double-blind placebo-controlled trial of intravenous antioxidant therapy in predicted severe pancreatitis
ISRCTN | ISRCTN56033334 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN56033334 |
Secondary identifying numbers | N0226121484 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 27/04/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Simon Galloway
Scientific
Scientific
Department of Surgery
South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom
Phone | +44 (0)161 291 2404/5 |
---|---|
Simon.Galloway@smuht.nwest.nhs.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study objectives | Either anti-oxidants are of benefit in acute pancreatitis in which case all patients with severe disease should have the benefit of this therapy or they are of no benefit and should no longer be used. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Pancreatitis |
Intervention | Multi-centre, randomised double-blind placebo-controlled trial: Group A - Maximal conventional therapy plus intravenous anti-oxidants for 7 days Group B - Maximal conventional therapy plus placebo |
Intervention type | Supplement |
Primary outcome measure | Change in multiple organ dysfunction score. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 03/02/2003 |
Completion date | 03/02/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 225 |
Key inclusion criteria | In total 150 patients with predicted severe acute pancreatitis and approx 75 controls will be recruited over the four centres. Approximately 30 patients at SMUHT. |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 03/02/2003 |
Date of final enrolment | 03/02/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Surgery
Manchester
M23 9LT
United Kingdom
M23 9LT
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Government
South Manchester University Hospitals NHS Trust (SMUHT) (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | Results | 01/10/2007 | Yes | No |